Article

T cell immunity of the nonadjuvanted HLA-restricted peptide COVID-19 vaccine

2023-03-14

Abstract excerpt

<title>Abstract</title> <p>Recently, the cases of breakthrough infection and restored virus of COVID-19 have increased after full vaccination, which might be contributed by immune surveillance escape or rebound virus. Here, artificial linear 9-mer human leucocyte antigen (HLA)-restricted UC peptides are designed based on the well-conserved S2 region of the COVID-19 spike protein regardless of rapid mutation and g...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 004a6015-ce78-5f2a-a6d2-c5ffd8c2f146
DOI: 10.21203/rs.3.rs-2119898/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

T cell immunity of the nonadjuvanted HLA-restricted peptide COVID-19 vaccineDOI 10.21203/rs.3.rs-2119898/v1Read

T-cell immunity induced by a nonadjuvanted HLA-restricted peptide COVID-19 vaccineSemantic proximity Read

Nanocell COVID-19 vaccine elicits iNKT-licensed dendritic cells to produce high affinity antibodies neutralizing Variants of ConcernSemantic proximity Read

Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.Semantic proximity Read

Cytotoxic T-cell-based vaccine against SARS-CoV2: a hybrid immunoinformatic approachSemantic proximity Read

Essential Considerations During Vaccine Design against COVID-19 and Review of Pioneering Vaccine Candidate PlatformsSemantic proximity Read

A review of leading COVID-19 vaccines, the quest for immune protection, and its key challenges. Part 3: Covid-19 vaccines – Key challenges and translational scienceSemantic proximity Read

Screening of HLA-A restricted T cell epitopes of SARS-CoV-2 and induction of CD8 <sup>+</sup> T cell responses in HLA-A transgenic miceSemantic proximity Read

Phase I Trial of a Multi-Peptide COVID-19 Vaccine for the Induction of SARS-CoV-2 T-Cell ImmunitySemantic proximity Read

Tissue-resident memory CD8 T-cell responses elicited by a single injection of a multi-target COVID-19 vaccineSemantic proximity Read

SARS-CoV-2 variant B.1.1.7 caused HLA-A2 <sup>+</sup> CD8 <sup>+</sup> T cell epitope mutations for impaired cellular immune responseSemantic proximity Read

Identification of a promiscuous conserved CTL epitope within the SARS-CoV-2 spike proteinSemantic proximity Read

CD8+ T Cell Epitope Variations Suggest a Potential Antigen Presentation Deficiency for Spike Protein of SARS-CoV-2Semantic proximity Read